Article Sidebar

PDF
Date Published: 10/03/2021
Abstract Views: 1037
Views PDF: 447
DOI: https://doi.org/10.51298/vmj.v498i1.51
Issue
Vol. 498 No. 1 (2021)
Section
Các bài báo
How to Cite
Trung Anh, Đặng, Bùi Hải, H., & Duy Tôn, M. (2021). FACTORS ASSOCIATED WITH DOOR-TO-NEEDLE TIME IN PATIENTS WITH ACUTE ISCHEMIC STROKE TREATED BY INTRAVENOUS FIBRINOLYTIC. Vietnam Medical Journal, 498(1). https://doi.org/10.51298/vmj.v498i1.51

FACTORS ASSOCIATED WITH DOOR-TO-NEEDLE TIME IN PATIENTS WITH ACUTE ISCHEMIC STROKE TREATED BY INTRAVENOUS FIBRINOLYTIC

Đặng Trung Anh1, Hoàng Bùi Hải2,, Mai Duy Tôn3
1 Trường Đại học Y Hà Nội
2 Bệnh viện Đại học Y Hà Nội
3 Bệnh viện Bạch Mai

Main Article Content

Abstract

The study aimed to describe factors associated with door-to-needle time (cửa - kim), the time from arrival to intravenous thrombolytic administration in patients with acute ischemic stroke. This was retrospective observational study at Hanoi Medical University and Bach Mai Hospitals on 124 patients who were diagnosed as acute ischemic stroke and treated with thrombolysis. The results showed that pre-hospital contact, admission during office hours and the length of door-to-examination (DTE) time were independent factors related to cửa - kim time less than 60 minutes. From these results, it was possible to improve the process and reduce the cửa - kim time, thereby improving the quality of treatment in patients with acute ischemic stroke.

Article Details

Keywords

door-to-needle, acute ischemic stroke, ischemic stroke, intravenous thrombolysis

References

1. Benjamin Emelia J, Virani Salim S, Callaway Clifton W, et al. Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association. Circulation. 2018;137(12):e67-e492.
2. World Health Organization. The top 10 causes of death. https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death. Accessed Nov 01, 2020.
3. Yamanashi H, Ngoc MQ, Huy TV, et al. Population-Based Incidence Rates of First-Ever Stroke in Central Vietnam. PLoS One. 2016; 11(8): e0160665. Accessed 2016.
4. Micieli G, Marcheselli S, Tosi PA. Safety and efficacy of alteplase in the treatment of acute ischemic stroke. Vasc Health Risk Manag. 2009;5(1):397-409.
5. Hajjar K, Kerr DM, Lees KR. Thrombolysis for acute ischemic stroke. Journal of Vascular Surgery. 2011; 54(3):901-907.
6. Fernandes D, Umasankar U. Improving Door to Needle time in Patients for Thrombolysis. BMJ Qual Improv Rep. 2016;5(1):u212969.w215150.
7. Man S, Xian Y, Holmes DN, et al. Association Between Thrombolytic Door-to-Needle Time and 1-Year Mortality and Readmission in Patients With Acute Ischemic Stroke. JAMA. 2020;323(21):2170-2184.
8. Powers WJ, Rabinstein AA, Ackerson T, et al. 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2018;49(3):e46-e99.
9. Meretoja A, Weir L Fau - Ugalde M, Ugalde M Fau - Yassi N, et al. Helsinki model cut stroke thrombolysis delays to 25 minutes in Melbourne in only 4 months. (1526-632X (Electronic)).